Simulations Plus, Inc.
NASDAQSimulations Plus has a compelling story to tell this week: a brand-new collaboration with Nvidia to scale GPU-accelerated, AI-assisted drug modeling workflows — announced on May 6 — landed as the stock was already up 31% in a month. The tension worth watching is straightforward. A credible catalyst is driving the price; insiders are moving the other direction. The insider angle is…
Snapshot as of 8 May 2026
Simulations Plus has a compelling story to tell this week: a brand-new collaboration with Nvidia to scale GPU-accelerated, AI-assisted drug modeling workflows — announced on May 6 — landed as the stock was already up…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLP — free to start on ORTEX.
Sign up for free →Open SLP on ORTEX